HB2457In Committee

Amends TCA Title 4; Title 56 and Title 71.

Tennessee HB2457 requires managed care organizations and pharmacy benefits managers contracted with the bureau to reimburse claims for long-acting injectable drugs used for the treatment and prevention of human immunodeficiency virus (HIV). This bill affects healthcare providers, including pharmacies, physician's offices, clinics, ambulatory surgical treatment centers, and hospitals that administer these medications. Key provisions include the mandate for reimbursement specifically for long-acting injectable HIV treatments.

What moved, what's on next week's agenda, new filings — every Monday, from the public record, free.

No account. Unsubscribe in one click.

Overview

Tennessee HB2457 requires managed care organizations and pharmacy benefits managers contracted with the bureau to reimburse claims for long-acting injectable drugs used for the treatment and prevention of human immunodeficiency virus (HIV). This bill affects healthcare providers, including pharmacies, physician's offices, clinics, ambulatory surgical treatment centers, and hospitals that administer these medications. Key provisions include the mandate for reimbursement specifically for long-acting injectable HIV treatments.

Track Tennessee Legislation Like a Pro

Join hundreds of professionals using LegisGo to stay ahead of legislative changes.

Instant Alerts

Get notified when bills you track move through the legislature

AI Summaries

Understand complex legislation in seconds with AI-powered analysis

Full Access

All 132 legislators, committee schedules, and voting records

Sponsor

Harris, Torrey

Details
Session

114th General Assembly

Introduced

February 3, 2026

Last Action

March 3, 2026

Taken off notice for cal in s/c Tenncare Subcommittee of Insurance Committee

Subjects
TennCarePharmacy, PharmacistsHealth Care

Want to track this bill? Get instant alerts and AI-powered insights.

HB2457: Amends TCA Title 4; Title 56 and Title 71. | LegisGo